View all trials
Are you a member? Sign in above to view additional information
  • Study title
    Phase I/Ib trial of combined 5’azacitidine and carboplatin for recurrent/refractory pediatric brain and solid tumors
  • Protocol ID
    COZMOS (OZM-077)
  • Disease
    Disease Type Disease Subtype
    Brain and Spinal Tumours
    Ependymoma
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Monash Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
    Perth Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
    Royal Children's Hospital Melbourne
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 1
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    01/09/2019
  • Study close date
    31/12/2021
  • Study chair
    Jordan Hansford
  • Sponsor
    Hospital for Sick Children, Toronto, Canada
Back to search results